CN1102399C - Antilipemic blood circulation promoting xueluofu capsale - Google Patents

Antilipemic blood circulation promoting xueluofu capsale Download PDF

Info

Publication number
CN1102399C
CN1102399C CN00110506A CN00110506A CN1102399C CN 1102399 C CN1102399 C CN 1102399C CN 00110506 A CN00110506 A CN 00110506A CN 00110506 A CN00110506 A CN 00110506A CN 1102399 C CN1102399 C CN 1102399C
Authority
CN
China
Prior art keywords
grams
radix
early
present
cerebral thrombosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN00110506A
Other languages
Chinese (zh)
Other versions
CN1279970A (en
Inventor
张庆玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN00110506A priority Critical patent/CN1102399C/en
Publication of CN1279970A publication Critical patent/CN1279970A/en
Application granted granted Critical
Publication of CN1102399C publication Critical patent/CN1102399C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a superficial-venule enduing fat-descending pulse-invigoration capsule, particularly to Chinese drug preparations for curing diseases, such as early arteriosclerosis, cerebral thrombosis auras, etc. The present invention is mainly prepared by antlers, fleece flower roots, cherokee rose fruits, cassia seeds, oriental wormwood, water plantain, haw, rhubarb, curcuma roots, chuanxiong rhizomes, etc. The present invention has the advantages of short treatment courses for treating the early arteriosclerosis, the cerebral thrombosis auras, phlebitis, early vasculitis, cerebral thrombosis sequelae, coronary diseases, etc., high cure rate and difficult recurrence.

Description

Fat-reducing are blood-circulation promoting capsule
The present invention relates to a kind of early stage arteriosclerosis, cerebral thrombosis tendency, phlebitis, middle medicament of diseases such as stage angiitis, cerebral infarction sequela, coronary heart disease early for the treatment of.
The early stage arteriosclerosis of existing treatment, cerebral thrombosis tendency, phlebitis, early the medicament cure rate of stage angiitis, cerebral infarction sequela, coronary heart disease is low, and the course of treatment is long, weak curative effect, relapse rate height.
The objective of the invention is to develop the above-mentioned disease short treating period of a kind of treatment, good effect, the cure rate height is difficult for the Chinese medicine preparation-Fat-reducing are blood-circulation promoting capsule that recurs.
The object of the present invention is achieved like this:
1. get Radix Polygoni Multiflori Preparata 20 grams, Fructus Rosae Laevigatae 15 grams, Semen Cassiae 15 grams, Herba Artemisiae Scopariae 15 grams, Rhizoma Alismatis 20 grams, Fructus Crataegi 20 grams, Radix Et Rhizoma Rhei 6 grams, Radix Curcumae 20 grams, Rhizoma Chuanxiong 15 grams;
2. each medicine in will be 1. respectively gets 1/3, adds Cornu Cervi Pantotrichum 3 grams, mixes oven dry, pulverizes, and porphyrize is standby;
3. each medicine remainder mixings decocting is three times in will be 1., about 250 milliliters of meter taking liquids with 2. in gained medicated powder mix, oven dry, porphyrize incapsulates, every capsules powder charge 0.4 restrains.
Usage and dosage: every day oral secondary, early, the evening each once, each 5.
Advantage of the present invention is to be used for the treatment of early stage arteriosclerosis that hypercholesterolemia, hypertriglyceridemia, high fibremia, blood high viscosity syndrome cause, cerebral thrombosis tendency, phlebitis, diseases such as stage angiitis, cerebral infarction sequela, coronary heart disease early, general medication can be cured in two months, cure rate reaches more than 50%, obvious effective rate is more than 40%, total effective rate 100%, and be difficult for recurrence.
Embodiment:
1. get Radix Polygoni Multiflori Preparata 20 grams, Fructus Rosae Laevigatae 15 grams, Semen Cassiae 15 grams, Herba Artemisiae Scopariae 15 grams, Rhizoma Alismatis 20 grams, Fructus Crataegi 20 grams, Radix Et Rhizoma Rhei 6 grams, Radix Curcumae 20 grams, Rhizoma Chuanxiong 15 grams;
2. each medicine in will be 1. respectively gets 1/3, adds Cornu Cervi Pantotrichum 3 grams, mixes oven dry, pulverizes, and porphyrize is standby;
3. each medicine remainder mixings decocting is three times in will be 1., about 250 milliliters of meter taking liquids with 2. in gained medicated powder mix, oven dry, porphyrize incapsulates, every capsules powder charge 0.4 restrains.
Illustrate about pharmacology of the present invention: Cornu Cervi Pantotrichum, Radix Polygoni Multiflori Preparata, Fructus Rosae Laevigatae, the clear invigorating the liver and kidney of Semen Cassiae, controlling nocturnal emission with astringent drugs gas, benefiting essence-blood in the side; Herba Artemisiae Scopariae, Rhizoma Alismatis eliminating dampness and diuresis eliminate the phlegm; Fructus Crataegi, Radix Et Rhizoma Rhei eliminate indigestion purging FU-organs blood stasis dispelling; Radix Curcumae, Rhizoma Chuanxiong blood circulation and removing stasis, the circulation of qi promoting intestinal stasis relieving.All has hypolipemic function preferably according to modern pharmacological research Radix Polygoni Multiflori Preparata, Rhizoma Alismatis, Fructus Crataegi, Radix Et Rhizoma Rhei, Radix Curcumae, Rhizoma Chuanxiong, Semen Cassiae.Clinical verification blood fat reducing, anticoagulant are evident in efficacy.

Claims (1)

1, Fat-reducing are blood-circulation promoting capsule is characterized in that:
1. get Radix Polygoni Multiflori Preparata 20 grams, Fructus Rosae Laevigatae 15 grams, Semen Cassiae 15 grams, Herba Artemisiae Scopariae 15 grams, Rhizoma Alismatis 20 grams, Fructus Crataegi 20 grams, Radix Et Rhizoma Rhei 6 grams, Radix Curcumae 20 grams, Rhizoma Chuanxiong 15 grams;
2. each medicine in will be 1. respectively gets 1/3, adds Cornu Cervi Pantotrichum 3 grams, mixes oven dry, pulverizes, and porphyrize is standby;
3. each medicine remainder mixings decocting is three times in will be 1., about 250 milliliters of meter taking liquids with 2. in gained medicated powder mix, oven dry, porphyrize incapsulates, every capsules powder charge 0.4 restrains.
CN00110506A 2000-06-09 2000-06-09 Antilipemic blood circulation promoting xueluofu capsale Expired - Fee Related CN1102399C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00110506A CN1102399C (en) 2000-06-09 2000-06-09 Antilipemic blood circulation promoting xueluofu capsale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00110506A CN1102399C (en) 2000-06-09 2000-06-09 Antilipemic blood circulation promoting xueluofu capsale

Publications (2)

Publication Number Publication Date
CN1279970A CN1279970A (en) 2001-01-17
CN1102399C true CN1102399C (en) 2003-03-05

Family

ID=4580494

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00110506A Expired - Fee Related CN1102399C (en) 2000-06-09 2000-06-09 Antilipemic blood circulation promoting xueluofu capsale

Country Status (1)

Country Link
CN (1) CN1102399C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112806A1 (en) * 2003-06-26 2004-12-29 Canada Changmin Nutraceutique Co. Ltd Composition for treating or preventing neural disorders
WO2010143059A1 (en) 2009-06-12 2010-12-16 Generex Pharmaceuticals, Inc. Compositioins and preparation methods of compositions for prevention and treatment of hypertension
CN105267939A (en) * 2015-11-30 2016-01-27 吕翠云 Traditional Chinese medicine composition for treating superficial phlebitis
CN107114728A (en) * 2017-05-17 2017-09-01 柳州市北部科技服务有限公司 A kind of Roselle diet food and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1103302A (en) * 1993-12-01 1995-06-07 董兴武 Hypolipemic and heart tonifying capsule and preparing process thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1103302A (en) * 1993-12-01 1995-06-07 董兴武 Hypolipemic and heart tonifying capsule and preparing process thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《实用中医内科杂志》1991,5(1) 1991-02-01 王宝龙等,"轻身饮降脂减肥作用临床观察" *
《江苏中医》1995,16(2) 1995-03-01 王兴昌,"复方降脂饮治疗高血脂症29例";《辽宁中医杂志》1995,22(2) 1995-03-01 张福生等,"降脂汤治疗慢性肾功能不全35例";《实用中医内科杂志》1991,5(1) 1991-02-01 王宝龙等,"轻身饮降脂减肥作用临床观察" *
《江苏中医》1995,16(2) 1995-03-01 王兴昌,"复方降脂饮治疗高血脂症29例" *
《辽宁中医杂志》1995,22(2) 1995-03-01 张福生等,"降脂汤治疗慢性肾功能不全35例" *

Also Published As

Publication number Publication date
CN1279970A (en) 2001-01-17

Similar Documents

Publication Publication Date Title
CN103463528B (en) Traditional Chinese medicine composition for treating chronic eczema
CN101129593A (en) Traditional Chinese medicine for treating senile habitual constipation
CN100400094C (en) Traditional Chinese medicine for treating hepatitis B and its preparing process
CN104337974A (en) Drug for treating metrorrhagia and preparation method thereof
CN101987138A (en) Chinese medicinal preparation for treating impotence
CN1102399C (en) Antilipemic blood circulation promoting xueluofu capsale
CN1071123C (en) Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites
CN1063650C (en) Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN1186056C (en) medicine for treating hyperosteogeny
CN1332705C (en) Chinese medicine for treating liver diseases
CN1060073C (en) Externally used medicine bag for curing chronic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process
CN109833375A (en) A kind of medical ointment plaster and preparation method thereof for treating rheumatic arthritis
CN103690833B (en) A kind of Chinese medicine for the treatment of rheumatic arthritis
CN102038834A (en) Traditional Chinese medicine preparation for preventing and treating cancers
CN101152394A (en) Traditional Chinese medicine for treating chronic active hepatitis
CN1698801A (en) Capsule for treating hemiplegia and rheumatism
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer
CN110801468A (en) Traditional Chinese medicine composition for treating liver cirrhosis, pharmaceutical preparation and preparation method of tablet
CN104338091A (en) Drug for treating acne and whelk and preparation method thereof
CN102100770A (en) Traditional Chinese medicine preparation for treating hyperlipidemia
CN102100824A (en) Traditional Chinese medicine for treating difficult urination
CN102274373A (en) Traditional Chinese medicine for treating hypomenorrhea
CN1145802A (en) Rehabilitation powder for hepatitis B
CN1156039A (en) Smoking stick for curing nasosinusitis
CN1135910A (en) Capsule of Bidoukang

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee